Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Yoshitoshi Ohtsuka"'
Autor:
Keiji, Nogami, Masashi, Taki, Tadashi, Matsushita, Tetsuhito, Kojima, Toshiaki, Oka, Shouichi, Ohga, Kiyoshi, Kawakami, Michio, Sakai, Takashi, Suzuki, Satoshi, Higasa, Yasuo, Horikoshi, Keiko, Shinozawa, Shogo, Tamura, Koji, Yada, Masue, Imaizumi, Yoshitoshi, Ohtsuka, Fuminori, Iwasaki, Masao, Kobayashi, Junki, Takamatsu, Hideyuki, Takedani, Hisaya, Nakadate, Yoko, Matsuo, Takeshi, Matsumoto, Teruhisa, Fujii, Katsuyuki, Fukutake, Akira, Shirahata, Akira, Yoshioka, Midori, Shima
Publikováno v:
Haemophilia : the official journal of the World Federation of HemophiliaREFERENCES. 28(5)
Inhibitor-development is a serious complication in patients with haemophilia (PwH). Previous studies reported that therapeutic and genetic factors could be associated with these alloantibodies. Relevant clinical features such as genetic-background an
Autor:
Hideki Muramatsu, Yoshiyuki Takahashi, Shouichi Ohga, Yoshitoshi Ohtsuka, Hiroyuki Shimada, Hiromasa Yabe, Kazuko Hamamoto, Ryoji Kobayashi, Seiji Kojima, Masami Inoue, Akira Ohara, Hiroshi Yagasaki, Hiroyuki Shichino
Publikováno v:
Annals of Hematology. 93:747-752
Patients with severe aplastic anemia (SAA) and an absolute neutrophil count (ANC) of 0 typically have fatal outcomes. We defined fulminant AA (FAA) as ANC = 0 for at least 2 weeks prior to and after immunosuppressive therapy (IST). We analyzed the ou
Autor:
Akira Kokubunji, Takakuni Tanizawa, Kazuhiro Ikegame, Yoshitoshi Ohtsuka, Masaya Okada, Tatsuya Fujioka, Noriko Fujita, Katsuji Kaida, Junko Ikemoto, Shunro Kai, Noriaki Okamoto, Hiroyasu Ogawa, Satoshi Yoshihara, Junichiro Ono, Kyoko Taniguchi
Publikováno v:
Transfusion. 52:2646-2652
BACKGROUND Granulocyte mobilization and harvesting, the two major phases of granulocyte collection, have not been standardized. STUDY DESIGN AND METHODS The data on 123 granulocyte collections were retrospectively investigated for the effect of the m
Autor:
Hideki Muramatsu, Yoshitoshi Ohtsuka, Seiji Kojima, Hiroyuki Fujisaki, Nao Yoshida, Akira Shimada, Youji Asada, Naohiro Akita, Sayoko Doisaki, Shosuke Sunami, H Sakaguchi, Yoshiyuki Takahashi, Olfat Ismael, Asahito Hama, Masafumi Ito
Publikováno v:
Pediatric Blood & Cancer. 59:530-535
Background Acquired somatic mutations of JAK2 have been reported to play a pivotal role in the pathogenesis of BCR-ABL1-negative myeloproliferative neoplasm (MPN). However, the molecular characteristics of childhood MPN remain to be elucidated. Patie
Autor:
Akira Ohara, Akira Kikuchi, Seiji Kojima, Hiroshi Yagasaki, Daisuke Hasegawa, Masahiro Tsuchida, Yoshitoshi Ohtsuka, Tatsutoshi Nakahata, Masami Inoue, Atsushi Manabe
Publikováno v:
Pediatric Blood & Cancer. 53:1011-1015
Background Although hematopoietic stem cell transplantation (HSCT) is offered as a curative therapy for pediatric myelodysplastic syndrome (MDS), it may cause severe complications and mortality. Several reports have shown the efficacy of immunosuppre
Autor:
Yoshitoshi Ohtsuka, Yasuhiro Ebihara, Kohichiro Tsuji, Yuka Wada, Tadayasu Kanda, Kazuo Ogami, Kumiko Ishikawa, Hirohide Kawasaki, Toshihisa Tsuruta, Atsushi Manabe, Daisuke Hasegawa
Publikováno v:
International Journal of Hematology. 86:446-450
We describe the clinical course of a patient who experienced refractory pure red cell aplasia (PRCA) after undergoing HLA-matched allogeneic peripheral blood stem cell transplantation (allo-PBSCT) for refractory anemia with an excess of blasts in tra
Autor:
Takeshi Inukai, Megumi Oda, Toshiya Inaba, Y Miyajima, M Ohtake, N Kawamura, Fumio Yanai, Hiroko Inada, Ryosuke Miyaji, Y Nagatoshi, Yoshitoshi Ohtsuka, Asahito Hama, Hidemitsu Kurosawa, Kumiko Goi, Mikiya Endo, Masue Imaizumi, Shinpei Nakazawa, Hiroaki Goto, Motoaki Chin, Akira Morimoto, Masahiro Saito, Kanji Sugita, Akio Tawa, Kinuko Hirose
Publikováno v:
Leukemia. 21:288-296
Hypercalcemia is relatively rare but clinically important complication in childhood leukemic patients. To clarify the clinical characteristics, mechanisms of hypercalcemia, response to management for hypercalcemia, incidence of t(17;19) and final out
Autor:
Yoshitoshi Ohtsuka, Tatsutoshi Nakahata, Takakuni Tanizawa, Kohichiro Tsuji, Daisuke Hasegawa, Yuji Zaike, Atsushi Manabe, Hirohide Kawasaki, Sumiko Watanabe
Publikováno v:
Blood. 106:3134-3141
Juvenile myelomonocytic leukemia (JMML) is a clonal myeloproliferative/myelodysplastic disorder of early childhood with a poor prognosis. JMML cells are characterized by hypersensitivity to granulocyte-macrophage colony-stimulating factor (GM-CSF) ca
Autor:
Xinan Wang, Hiroyuki Fujisaki, Shouichi Ohga, Yuko Sekiya, Seiji Kojima, Daiichiro Hasegawa, Asahito Hama, Nozomu Kawashima, Olfat Ismael, Hideki Muramatsu, Toshihiko Imamura, Akira Shimada, Yoshiyuki Kosaka, Yoshiyuki Takahashi, Yinyan Xu, Atsushi Narita, Yoshitoshi Ohtsuka, Shosuke Sunami, Yusuke Okuno
Publikováno v:
International Journal of Hematology. 104:266-267
Autor:
Nao Yoshida, Kazuko Kudo, Yoshitoshi Ohtsuka, Hiromasa Yabe, Kazuo Sakashita, Kenichiro Watanabe, Hidemitsu Kurosawa, Atsushi Manabe, Jiro Inagaki, Harumi Kakuda, Miharu Yabe
Publikováno v:
International journal of hematology. 101(2)
We report the outcomes of 30 patients with juvenile myelomonocytic leukemia (JMML) who received unmanipulated hematopoietic stem cell transplantation (HSCT) with oral or intravenous busulfan, fludarabine, and melphalan between 2001 and 2011. Mutation